2025-03-28FDA approves durvalumab for muscle invasive bladder cancerTrial NIAGARADrugs Imfinzi (durvalumab) · Anti-PD-L1 antibody, gemcitabine · Pyrimidine analog, cisplatin · Platinum agentConditionGenitourinary
2024-03-07FDA approves nivolumab in combination with cisplatin and gemcitabine for unresectable or metastatic urothelial carcinomaTrial CheckMate901Drugs Opdivo (nivolumab) · Anti-PD-1 antibody, cisplatin · Platinum agent, gemcitabine · Pyrimidine analogConditionGenitourinary